Jason Bouvier
Stock Analyst at Scotiabank
(0.37)
# 3,362
Out of 4,667 analysts
9
Total ratings
40%
Success rate
-16.62%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $50 → $53 | $45.74 | +15.87% | 3 | Nov 18, 2024 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $75.90 | +44.93% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $40.83 | +46.95% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $16.16 | +110.40% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $33.78 | +68.74% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.70 | - | 1 | Apr 20, 2021 |
Ovintiv
Nov 18, 2024
Maintains: Sector Outperform
Price Target: $50 → $53
Current: $45.74
Upside: +15.87%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $75.90
Upside: +44.93%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $40.83
Upside: +46.95%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $16.16
Upside: +110.40%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $33.78
Upside: +68.74%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.70
Upside: -